Gilead Submits NDA to U.S. FDA for F... - HFI Connect - Hep...

HFI Connect - Hepatitis

960 members1,215 posts

Gilead Submits NDA to U.S. FDA for Fixed-Dose Combination of Sofosbuvir/Velpatasvir for Treatment of All Six Genotypes of Hep C

kcohen profile image
0 Replies

hepatitiscnewdrugs.blogspot...

Written by
kcohen profile image
kcohen
To view profiles and participate in discussions please or .